🇺🇸 FDA
Patent

US 9439935

Recombinant rift valley fever (RVF) viruses and methods

granted A61KA61K2039/525A61K2039/5254

Quick answer

US patent 9439935 (Recombinant rift valley fever (RVF) viruses and methods) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/525, A61K2039/5254, A61K35/76, A61K39/00